Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size, Status and Forecast 2020-2026

Published: December 2020

No. of Pages: 99

Price:

Single User License: US $ 3900 US $ 2925
Corporate User License: US $ 7800 US $ 5850

Report Description
Table of Contents

Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
- PCR
- In-situ Hybridization
- Immunohistochemistry
- Sequencing
- Others

Market segment by Application, split into
- Oncology
- Neurological Disorders
- Cardiovascular Disease
- Immunological Disorders
- Others

Based on regional and country-level analysis, the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market has been segmented as follows:
- North America
- - United States
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Australia
- Latin America
- - Mexico
- - Brazil
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - UAE

In the competitive analysis section of the report, leading as well as prominent players of the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
- Qiagen NV
- GE Healthcare
- Agilent Technologies
- F Hoffman La Roche
- Foundation Medicine
- Thermo Fisher Scientific Inc.
- Leica Biosystems Nussloch GmBH

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Type
1.3.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Growth Rate by Type: 2020 VS 2026
1.3.2 PCR
1.3.3 In-situ Hybridization
1.3.4 Immunohistochemistry
1.3.5 Sequencing
1.3.6 Others
1.4 Market by Application
1.4.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application: 2020 VS 2026
1.4.2 Oncology
1.4.3 Neurological Disorders
1.4.4 Cardiovascular Disease
1.4.5 Immunological Disorders
1.4.6 Others
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Perspective (2015-2026)
2.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Growth Trends by Regions
2.2.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Historic Market Share by Regions (2015-2020)
2.2.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Forecasted Market Size by Regions (2021-2026)
2.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Industry Dynamic
2.3.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Trends
2.3.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Drivers
2.3.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Challenges
2.3.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Players by Market Size
3.1.1 Global Top Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Players by Revenue (2015-2020)
3.1.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Players (2015-2020)
3.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue
3.4 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Concentration Ratio
3.4.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue in 2019
3.5 Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Area Served
3.6 Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product Solution and Service
3.7 Date of Enter into Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Breakdown Data by Type
4.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Historic Market Size by Type (2015-2020)
4.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Forecasted Market Size by Type (2021-2026)

5 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Breakdown Data by Application
5.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Historic Market Size by Application (2015-2020)
5.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2015-2026)
6.2 North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020)
6.3 North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020)
6.4 North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2015-2026)
7.2 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020)
7.3 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020)
7.4 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2015-2026)
8.2 Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020)
8.3 Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020)
8.4 Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia

9 Latin America
9.1 Latin America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2015-2026)
9.2 Latin America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020)
9.3 Latin America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020)
9.4 Latin America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2015-2026)
10.2 Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020)
10.3 Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020)
10.4 Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE

11Key Players Profiles
11.1 Qiagen NV
11.1.1 Qiagen NV Company Details
11.1.2 Qiagen NV Business Overview
11.1.3 Qiagen NV Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
11.1.4 Qiagen NV Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020))
11.1.5 Qiagen NV Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
11.2.4 GE Healthcare Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
11.2.5 GE Healthcare Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
11.3.4 Agilent Technologies Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
11.3.5 Agilent Technologies Recent Development
11.4 F Hoffman La Roche
11.4.1 F Hoffman La Roche Company Details
11.4.2 F Hoffman La Roche Business Overview
11.4.3 F Hoffman La Roche Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
11.4.4 F Hoffman La Roche Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
11.4.5 F Hoffman La Roche Recent Development
11.5 Foundation Medicine
11.5.1 Foundation Medicine Company Details
11.5.2 Foundation Medicine Business Overview
11.5.3 Foundation Medicine Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
11.5.4 Foundation Medicine Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
11.5.5 Foundation Medicine Recent Development
11.6 Thermo Fisher Scientific Inc.
11.6.1 Thermo Fisher Scientific Inc. Company Details
11.6.2 Thermo Fisher Scientific Inc. Business Overview
11.6.3 Thermo Fisher Scientific Inc. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
11.6.4 Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
11.6.5 Thermo Fisher Scientific Inc. Recent Development
11.7 Leica Biosystems Nussloch GmBH
11.7.1 Leica Biosystems Nussloch GmBH Company Details
11.7.2 Leica Biosystems Nussloch GmBH Business Overview
11.7.3 Leica Biosystems Nussloch GmBH Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
11.7.4 Leica Biosystems Nussloch GmBH Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
11.7.5 Leica Biosystems Nussloch GmBH Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
11.8.4 Pfizer Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
11.8.5 Pfizer Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Key Players of PCR
Table 3. Key Players of In-situ Hybridization
Table 4. Key Players of Immunohistochemistry
Table 5. Key Players of Sequencing
Table 6. Key Players of Others
Table 7. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions (2015-2020)
Table 11. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions (2021-2026)
Table 13. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Market Trends
Table 14. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Drivers
Table 15. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Challenges
Table 16. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Restraints
Table 17. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Players (2015-2020)
Table 19. Global Top Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) as of 2019)
Table 20. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Type (2015-2020)
Table 26. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 27. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Application (2015-2020) (US$ Million)
Table 28. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Application (2015-2020)
Table 29. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 30. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2015-2020)
Table 32. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2015-2020)
Table 34. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Country (2015-2020)
Table 36. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2015-2020)
Table 38. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2015-2020)
Table 40. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Country (2015-2020)
Table 42. Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020) (US$ Million)
Table 43. Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2015-2020)
Table 44. Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020) (US$ Million)
Table 45. Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2015-2020)
Table 46. Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Region (US$ Million) (2015-2020)
Table 47. Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Region (2015-2020)
Table 48. Latin America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020) (US$ Million)
Table 49. Latin America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2015-2020)
Table 50. Latin America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020) (US$ Million)
Table 51. Latin America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2015-2020)
Table 52. Latin America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Country (US$ Million) (2015-2020)
Table 53. Latin America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Country (2015-2020)
Table 54. Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2015-2020) (US$ Million)
Table 55. Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2015-2020)
Table 56. Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2015-2020) (US$ Million)
Table 57. Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2015-2020)
Table 58. Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Country (US$ Million) (2015-2020)
Table 59. Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Country (2015-2020)
Table 60. Qiagen NV Company Details
Table 61. Qiagen NV Business Overview
Table 62. Qiagen NV Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product
Table 63. Qiagen NV Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020) (US$ Million)
Table 64. Qiagen NV Recent Development
Table 65. GE Healthcare Company Details
Table 66. GE Healthcare Business Overview
Table 67. GE Healthcare Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product
Table 68. GE Healthcare Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020) (US$ Million)
Table 69. GE Healthcare Recent Development
Table 70. Agilent Technologies Company Details
Table 71. Agilent Technologies Business Overview
Table 72. Agilent Technologies Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product
Table 73. Agilent Technologies Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020) (US$ Million)
Table 74. Agilent Technologies Recent Development
Table 75. F Hoffman La Roche Company Details
Table 76. F Hoffman La Roche Business Overview
Table 77. F Hoffman La Roche Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product
Table 78. F Hoffman La Roche Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020) (US$ Million)
Table 79. F Hoffman La Roche Recent Development
Table 80. Foundation Medicine Company Details
Table 81. Foundation Medicine Business Overview
Table 82. Foundation Medicine Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product
Table 83. Foundation Medicine Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020) (US$ Million)
Table 84. Foundation Medicine Recent Development
Table 85. Thermo Fisher Scientific Inc. Company Details
Table 86. Thermo Fisher Scientific Inc. Business Overview
Table 87. Thermo Fisher Scientific Inc. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product
Table 88. Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020) (US$ Million)
Table 89. Thermo Fisher Scientific Inc. Recent Development
Table 90. Leica Biosystems Nussloch GmBH Company Details
Table 91. Leica Biosystems Nussloch GmBH Business Overview
Table 92. Leica Biosystems Nussloch GmBH Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product
Table 93. Leica Biosystems Nussloch GmBH Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020) (US$ Million)
Table 94. Leica Biosystems Nussloch GmBH Recent Development
Table 95. Pfizer Business Overview
Table 96. Pfizer Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product
Table 97. Pfizer Company Details
Table 98. Pfizer Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020) (US$ Million)
Table 99. Pfizer Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type: 2020 VS 2026
Figure 2. PCR Features
Figure 3. In-situ Hybridization Features
Figure 4. Immunohistochemistry Features
Figure 5. Sequencing Features
Figure 6. Others Features
Figure 7. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application: 2020 VS 2026
Figure 8. Oncology Case Studies
Figure 9. Neurological Disorders Case Studies
Figure 10. Cardiovascular Disease Case Studies
Figure 11. Immunological Disorders Case Studies
Figure 12. Others Case Studies
Figure 13. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Report Years Considered
Figure 14. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (US$ Million), YoY Growth 2015-2026
Figure 15. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions: 2020 VS 2026
Figure 16. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions (2021-2026)
Figure 17. Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Players in 2019
Figure 18. Global Top Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue in 2019
Figure 20. North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Canada Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Germany Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. France Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. U.K. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Italy Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Russia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Nordic Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. South Korea Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Australia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Rest of Asia-Pacific Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Latin America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Mexico Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Brazil Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Middle East & Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Turkey Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Saudi Arabia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. UAE Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Qiagen NV Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
Figure 46. GE Healthcare Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
Figure 47. Agilent Technologies Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
Figure 48. F Hoffman La Roche Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
Figure 49. Foundation Medicine Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
Figure 50. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
Figure 51. Leica Biosystems Nussloch GmBH Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
Figure 52. Pfizer Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

Write comment about above report:

Published By: QYResearch Group

Product Code: QYResearch Group692770

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size, Status and Forecast 2021-2027 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmacogenomics Technology/Theranostics/C...
Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market 2020 by Company, Regions, Type and Application, Forecast to 2025 Market Overview The global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 an...
2020-2025 Global and Regional Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report HNY Research projects that the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size...
Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market 2020 by Company, Type and Application, Forecast to 2025 Market Overview The global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 an...
Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Insights 2019, Global and Chinese Analysis and Forecast to 2024 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Pharmacogenomics Technology/Theranostics/Companion Diagnost...
COVID-19 Impact on Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market, Global Research Reports 2020-2021 This report covers market size and forecasts of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx), including the following market information: - Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Mar...
Global and Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size, Status and Forecast 2020-2026 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Scope and Market Size Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market is segmented by Type, and by Application. Players, stakeholders, and ...
Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Growth (Status and Outlook) 2020-2025 According to this study, over the next five years the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market will register a 7.1%% CAGR in terms of revenue, the global market size will reach $ 6421.6 million by 2025, from $ 4872....
Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size, Status and Forecast 2019-2025 In 2018, the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on th...
Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Report 2019 - Market Size, Share, Price, Trend and Forecast The global market size of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of 2024 with a CAGR of XX% from 2019 to 2024....

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *